These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11416613)

  • 1. How Low Should We Treat Blood Pressure and Why?
    Weir MR
    J Clin Hypertens (Greenwich); 1999 Nov; 1(3):199-208. PubMed ID: 11416613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing Cardiorenal Benefit in the Management of Hypertension: Achieve Blood Pressure Goals.
    Bakris GL
    J Clin Hypertens (Greenwich); 1999 Oct; 1(2):141-147. PubMed ID: 11416606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of control of high blood pressure and treatment recommendations in Canada.
    Khan N; Chockalingam A; Campbell NR
    Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target Organ Damage in Hypertension.
    Odama U; Bakris G
    J Clin Hypertens (Greenwich); 2000 Oct; 2(5):312-318. PubMed ID: 11416667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Missed Opportunity: Our Failure to Control Hypertension Optimally.
    Gifford RW
    J Clin Hypertens (Greenwich); 2000 Jan; 2(1):21-24. PubMed ID: 11416621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician Role in Lack of Awareness and Control of Hypertension.
    Hyman DJ; Pavlik VN; Vallbona C
    J Clin Hypertens (Greenwich); 2000 Oct; 2(5):324-330. PubMed ID: 11416669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Hypertension and the J Curve.
    Hansson L
    J Clin Hypertens (Greenwich); 1999 Oct; 1(2):136-140. PubMed ID: 11416605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Diastolic Blood Pressure be Excessively Lowered in the Treatment of Isolated Systolic Hypertension?
    Shorr RI; Somes GW
    J Clin Hypertens (Greenwich); 2000 Mar; 2(2):134-137. PubMed ID: 11416637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are current strategies for treating hypertension effective?
    Sica DA
    J Clin Hypertens (Greenwich); 2003; 5(3 Suppl 2):23-32. PubMed ID: 12826767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Multiple Drug Therapy for Controlling Hypertension in African Americans.
    Weir MR
    J Clin Hypertens (Greenwich); 2000 Mar; 2(2):99-108. PubMed ID: 11416633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated Systolic Hypertension Is a Strong Predictor of Cardiovascular and All-Cause Mortality in the Middle-Aged Population: Warsaw Pol-MONICA Follow up Project.
    Broda G
    J Clin Hypertens (Greenwich); 2000 Oct; 2(5):305-311. PubMed ID: 11416666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaching for aggressive blood pressure goals: role of angiotensin receptor blockade in combination therapy.
    Milani RV
    Am J Manag Care; 2005 Sep; 11(7 Suppl):S220-7. PubMed ID: 16180960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.